Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Chosa ApS
APS
Active
Advertising protection
CVR 43134477
Puggaardsgade 17, 1573
København V
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 4 years old
5 employees
www.chosa.bio
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Chosa ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2022
-2M
2023
-1M
2024
-2M
2025
EBITDA
DKK millions
0M
-1M
-2M
-3M
-4M
0M
2022
-2M
-200%
2023
-1M
+50%
2024
-3M
-200%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Gross profit
-467
-1.543
-1.131
-2.136
Staff expenses
-0
-0
-75
-711
EBITDA
-467
-1.543
-1.206
-2.847
Depreciation & amort.
-350
-500
-1.167
-500
EBIT
-817
-2.043
-2.373
-3.347
Net financials
-0
75
63
20
Profit before tax
-817
-1.967
-2.310
-3.326
Tax
-102
102
1.277
-694
Net profit
-715
-2.070
-3.587
-2.632
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
7.949
10.295
11.189
13.427
Equity
7.761
8.991
7.485
5.175
Long-term debt
0
936
2.477
5.321
Short-term debt
188
368
1.228
2.931
Total debt
188
1.304
3.705
8.252
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-284667900.0%
This company
2022
2025
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
2022
2025
Return on equity
-50.9%
This company
18.4%
Market median
-377% vs market
2022
2025
Net profit margin (of gross profit)
-263202400.0%
This company
2022
2025
Asset turnover (of gross profit)
-0.16×
This company
2022
2025
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-03-18 – 2022-12-31
View
PDF
More on Chosa ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
